Frist Cressey Ventures Announces Strategic Investment in ObjectiveHealth by Vitruvian Partners

Frist Cressey Ventures partnership, ObjectiveHealth, has secured a strategic investment from a leading global growth-focused investment firm, Vitruvian Partners.

NASHVILLE, TN, February 7, 2024 –

The Frist Cressey Ventures (FCV) team is excited to share the journey of ObjectiveHealth, an investment that stands out as a true testament to what happens when vision meets the right support. ObjectiveHealth is not just another success story for FCV; it is a trailblazer, redefining standards in healthcare, now alongside its new strategic investors, London-based Vitruvian Partners.

An innovator in clinical research, ObjectiveHealth seamlessly integrates clinical trials into the practices of physicians, while deploying proprietary advanced technology to identify and recruit patients for the trials. Central to their mission of prioritizing community health to promote health equity, ObjectiveHealth partners with community health centers to provide advanced care options and improve quality of care delivery in historically underserved and/or rural communities.

FCV is proud to have played a part in ObjectiveHealth’s growth since our Series A investment in 2019. Colleen Hoke, co-founder and CEO of ObjectiveHealth, appreciates the partnership: “Working with Frist Cressey Ventures has been a pivotal partner. FCV stands out as a mission-driven ally, genuinely committed to improving healthcare. Their approach goes beyond mere investment; they are a value-add partner in every sense, actively contributing to our mission and significantly aiding in our growth.”

Vitruvian Partners’ recent investment reflects a strong belief in ObjectiveHealth’s mission and its potential to continue reshaping the field of clinical research. Sophie Bower-Straziota, partner at Vitruvian, expressed her enthusiasm: “ObjectiveHealth has built an innovative and disruptive platform for advancing clinical research. As clinical research converges with healthcare, our investment will give ObjectiveHealth the resources to further develop its technology, broaden its reach into new regions, and deliver more treatment options for patients.”

On driving advancement and growth, Chris Booker, partner at FCV, shared, ” We are proud of the ObjectiveHealth team as they have continued to transform the clinical research space and improve patient lives. Welcoming the Vitruvian Life Sciences & Healthcare team further validates Objective’s novel clinical research model. They are the perfect partner to support the next phase of growth for Objective.”

Adding to this, Senator Bill Frist, M.D., co-founder and partner of FCV, expressed his enthusiasm about the collaboration: “The journey with ObjectiveHealth underscores the essence of what we aim to achieve at FCV. It’s about fostering innovation that leads to better healthcare outcomes. This new investment by Vitruvian Partners is a validation of that vision and the incredible potential of companies like ObjectiveHealth.”

Our journey with ObjectiveHealth, from its early stages to this significant milestone, reflects the core of FCV’s mission: to invest in and nurture early-stage companies that are not only successful but transformative in their impact on healthcare and patient outcomes. As we look to the future, we are excited to continue this progression, fostering innovation that resonates with our vision of a healthier, more accessible, and efficient healthcare system for all.

About Frist Cressey Ventures

Frist Cressey Ventures is a venture capital firm on a mission to transform healthcare and improve lives. Partnering with us means more than just capital. It means strategic support in the key areas that help businesses thrive, innovate, and deliver on their promise to affect systemic change. We invest in technology and service businesses with viable solutions that improve quality of care, system integration, patient outcomes, and population health and well-being. To learn more about Frist Cressey Ventures, visit our website at www.fcventures.com.

About Vitruvian Partners

Vitruvian Partners is an international growth-focused investor with offices across London, Stockholm, Munich, Luxembourg, San Francisco, Singapore and Shanghai. Vitruvian focuses on dynamic situations characterized by rapid growth and change across asset-light industries. Vitruvian has c.$16bn of active funds and is investing out of VIP V. The funds have backed many global winners and leaders in their sectors including: Just Eat, Skyscanner, Wise, CRF Health, KcasBio, Snow Software and Bitdefender. Further information can be found at www.vitruvianpartners.com.

###